# 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

> **NCT00757549** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 30 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** cisplatin
- **GENETIC:** TdT-mediated dUTP nick end labeling assay
- **OTHER:** 3'-deoxy-3'-[18F]fluorothymidine
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **RADIATION:** fludeoxyglucose F 18
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00757549
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-08
- **Final completion:** 2017-10-25
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00757549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00757549, "3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00757549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*